Nuvation Bio NUVB Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$145.99M+28.7% | -$204.63M+5.9% | -$217.48M-7.2% | -$202.9M+66.5% | -$606.38M-6.8% | ||
| $1.97M+13.0% | $1.74M+22.6% | $1.42M+35.5% | $1.05M+12.0% | $935K+36.9% | ||
| $37.07M+3.3% | $35.89M-5.8% | $38.1M+1.5% | $37.55M+7.0% | $35.09M+8.7% | ||
| $631K+104% | $310K+38.4% | $224K+1,936% | $11K— | —— | ||
| —— | —— | —— | —— | $414K-96.7% | ||
| —— | —— | —— | $17.21M+646% | $2.31M+240% | ||
| —— | —— | —— | —— | -$3.61M-153% | ||
| -$2.79M-430% | $846K-87.6% | $6.84M+26.6% | $5.4M0.0% | $5.4M-10.5% | ||
| $7.72M+74.4% | $4.42M— | —— | —— | —— | ||
| -$125.73M+27.5% | -$173.43M+8.7% | -$190M-13.0% | -$168.19M-6.9% | -$157.34M-20.6% | ||
| $7.98M-0.3% | $8M0.0% | $8M+3,440% | $226K+402% | $45K— | ||
| —— | —— | —— | $189.95M+12.2% | $169.34M+38.0% | ||
| $9.94M-1.7% | $10.11M+212% | $3.24M-25.5% | $4.35M-21.1% | $5.52M+23.8% | ||
| $11.37M-4.5% | $11.9M+42.8% | $8.33M-27.8% | $11.54M-34.8% | $17.7M+3.1% | ||
| $202.03M-0.2% | $202.54M— | —— | —— | —— | ||
| -$588K-122% | -$265K-125% | $1.08M+170% | $398K-34.1% | $604K+33.3% | ||
| —— | —— | —— | —— | —— | ||
| —— | $2.88M+28.3% | $2.25M+39.4% | $1.61M+65.1% | $976.25K+186% | ||
| —— | $197K-18.3% | $241K-15.4% | $285K-13.4% | $329K-11.8% | ||
| $631K+104% | $310K+38.4% | $224K+1,936% | $11K— | —— | ||
| $1.35M+24.8% | $1.09M+161% | $415K+102% | $205K+183% | -$248K— | ||
| —— | —— | $3.03M+466% | -$828K+49.4% | -$1.64M+58.5% | ||
| -$1.79M-529% | -$285K-121% | $1.39M+1,442% | $90K-88.3% | $770K+683% | ||
| $15.83M+38.7% | $11.41M+99.8% | $5.71M+934% | $552K+3,843% | $14K— | ||
| $7.72M+74.4% | $4.42M— | —— | —— | —— | ||
| -$15.22M-50.1% | -$10.14M-98.0% | -$5.12M-1,825% | -$266K— | —— | ||
| —— | —— | —— | $240K+700% | $30K+117% | ||
| $330K-6.8% | $354K— | —— | —— | —— | ||
| —— | —— | —— | -$150M— | —— | ||
| -$2.8M-445% | $812K-2.2% | $830K-8.7% | $909K+299% | $228K-75.6% | ||
| —— | —— | $4.28M-2.6% | $4.39M+2.0% | $4.31M+594% | ||
| —— | $3.87M+26.6% | $3.06M+36.2% | $2.25M+56.7% | $1.43M+131% | ||
| -$133.71M+26.3% | -$181.43M+8.4% | -$198M-17.6% | -$168.42M-7.0% | -$157.38M-20.7% | ||
| -$133.71M+26.3% | -$181.43M+8.4% | -$198M-17.6% | -$168.42M-7.0% | -$157.38M-20.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Nuvation Bio generate?
- Nuvation Bio (NUVB) generated -$125.7M in operating cash flow over the trailing twelve months.
- What is Nuvation Bio's free cash flow?
- After $8.0M of capital expenditures, Nuvation Bio's free cash flow was -$133.7M over the trailing twelve months, up 15.0% year over year.
- Where does Nuvation Bio's cash flow data come from?
- Every line is extracted from Nuvation Bio's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
